26.34
price up icon4.52%   1.14
after-market 시간 외 거래: 26.34
loading
전일 마감가:
$25.20
열려 있는:
$24.94
하루 거래량:
87,618
Relative Volume:
2.61
시가총액:
$300.25M
수익:
$9.71M
순이익/손실:
$-29.96M
주가수익비율:
-7.569
EPS:
-3.48
순현금흐름:
$-14.79M
1주 성능:
-4.53%
1개월 성능:
+6.38%
6개월 성능:
+0.23%
1년 성능:
+5.78%
1일 변동 폭
Value
$24.86
$26.64
1주일 범위
Value
$24.86
$28.09
52주 변동 폭
Value
$18.35
$35.00

Xoma Royalty Corp Stock (XOMA) Company Profile

Name
명칭
Xoma Royalty Corp
Name
전화
510-204-7239
Name
주소
2200 POWELL STREET, EMERYVILLE, CA
Name
직원
13
Name
트위터
@xomacorp
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
XOMA's Discussions on Twitter

XOMA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
XOMA
Xoma Royalty Corp
26.34 300.25M 9.71M -29.96M -14.79M -3.48
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-17 개시 The Benchmark Company Buy
2024-04-29 개시 Leerink Partners Outperform
2021-09-07 다운그레이드 Wedbush Outperform → Neutral
2021-06-29 개시 Aegis Capital Buy
2021-01-19 재확인 H.C. Wainwright Buy
2018-01-18 재확인 H.C. Wainwright Buy
2017-10-17 재개 H.C. Wainwright Buy
2017-09-05 업그레이드 Wedbush Neutral → Outperform
2017-06-12 개시 H.C. Wainwright Buy
2016-11-14 다운그레이드 Wedbush Outperform → Neutral
2016-03-11 재확인 Wedbush Outperform
2015-07-23 다운그레이드 Jefferies Buy → Hold
2015-07-22 다운그레이드 Ladenburg Thalmann Buy → Neutral
2015-07-22 다운그레이드 Piper Jaffray Overweight → Neutral
2014-10-10 재개 ROTH Capital Buy
2014-04-29 업그레이드 MLV & Co Hold → Buy
2014-03-11 다운그레이드 MLV & Co Buy → Hold
2014-03-05 재확인 Ladenburg Thalmann Buy
2013-10-31 재확인 MLV & Co Buy
2013-05-09 재확인 Ladenburg Thalmann Buy
2012-05-14 개시 Cowen & Co Outperform
2011-03-31 재확인 MLV Capital Buy
2011-03-23 재확인 RBC Capital Mkts Outperform
2011-01-06 재확인 Ladenburg Thalmann Buy
2011-01-04 재확인 Wedbush Outperform
모두보기

Xoma Royalty Corp 주식(XOMA)의 최신 뉴스

pulisher
Jun 18, 2025

XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

XOMA Preferred Stock Pays High-Yield Quarterly Dividend: 8.625% Series A, 8.375% Series B - Stock Titan

Jun 18, 2025
pulisher
Jun 16, 2025

Bank of America Corp DE Acquires 2,009 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World

Jun 16, 2025
pulisher
Jun 08, 2025

XOMA Co. (NASDAQ:XOMA) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Increases Stock Position in XOMA Co. (NASDAQ:XOMA) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

XOMA Co. (NASDAQ:XOMA) Shares Sold by BNP Paribas Financial Markets - Defense World

Jun 05, 2025
pulisher
Jun 02, 2025

BioInvent secured up to $30 million from XOMA Royalty - Biostock

Jun 02, 2025
pulisher
Jun 01, 2025

Wall Street Zen Upgrades XOMA (NASDAQ:XOMA) to Buy - Defense World

Jun 01, 2025
pulisher
May 31, 2025

HC Wainwright Issues Positive Outlook for XOMA Earnings - Defense World

May 31, 2025
pulisher
May 29, 2025

XOMA Co. (NASDAQ:XOMAO) Short Interest Update - Defense World

May 29, 2025
pulisher
May 29, 2025

XOMA Co. (NASDAQ:XOMAP) Short Interest Update - Defense World

May 29, 2025
pulisher
May 29, 2025

XOMA’s (XOMA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

May 29, 2025
pulisher
May 28, 2025

XOMA Royalty purchases mezagitamab royalty rights from BioInvent International for $30M - MSN

May 28, 2025
pulisher
May 28, 2025

XOMA stock holds Buy rating, $104 target from H.C. Wainwright - Investing.com

May 28, 2025
pulisher
May 28, 2025

XOMA stock holds Buy rating, $104 target from H.C. Wainwright By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 28, 2025

XOMA Royalty Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

May 28, 2025
pulisher
May 28, 2025

XOMA Stock: HC Wainwright & Co. Reiterates Buy Rating with $104 - GuruFocus

May 28, 2025
pulisher
May 27, 2025

XOMA Purchases Future Mezagitamab Royalty Interests from BioInve - GuruFocus

May 27, 2025
pulisher
May 27, 2025

XOMA Royalty (XOMA) Acquires Mezagitamab Interests from BioInvent - GuruFocus

May 27, 2025
pulisher
May 27, 2025

XOMA Royalty (XOMA) Acquires Mezagitamab Interests from BioInven - GuruFocus

May 27, 2025
pulisher
May 27, 2025

XOMA Royalty Purchases Mezagitamab Royalty and Milestone - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million - Yahoo Finance

May 27, 2025
pulisher
May 25, 2025

Northern Trust Corp Has $2.40 Million Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World

May 25, 2025
pulisher
May 23, 2025

XOMA (NASDAQ:XOMAO) Stock Price Up 0.1% – Still a Buy? - Defense World

May 23, 2025
pulisher
May 22, 2025

XOMA (NASDAQ:XOMAP) Trading Up 1.5% – Still a Buy? - Defense World

May 22, 2025
pulisher
May 20, 2025

Major Shareholder Sells Massive Chunk of Xoma Stock! - TipRanks

May 20, 2025
pulisher
May 19, 2025

Leerink Partnrs Analysts Boost Earnings Estimates for XOMA - Defense World

May 19, 2025
pulisher
May 18, 2025

FY2026 Earnings Estimate for XOMA Issued By Leerink Partnrs - Defense World

May 18, 2025
pulisher
May 16, 2025

Results: XOMA Royalty Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

XOMA Royalty First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 15, 2025
pulisher
May 14, 2025

XOMA Royalty Reports Strong Q1 2025 Results - TipRanks

May 14, 2025
pulisher
May 14, 2025

XOMA Royalty Corp Q1 2025 Earnings: EPS of $0.24, Revenue Surges to $15.9 Million, Exceeding Estimates - GuruFocus

May 14, 2025
pulisher
May 13, 2025

XOMA (XOMA) Surpasses Q1 Revenue Expectations with Strong Pipeli - GuruFocus

May 13, 2025
pulisher
May 13, 2025

XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

XOMA Royalty Corporation Q1 2025 Financial Results - TradingView

May 13, 2025
pulisher
May 13, 2025

XOMA Royalty Corp SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements - The Manila Times

May 13, 2025
pulisher
May 12, 2025

Wells Fargo & Company MN Grows Stock Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World

May 12, 2025
pulisher
May 11, 2025

Barclays PLC Acquires 1,528 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World

May 11, 2025
pulisher
May 07, 2025

XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference - GlobeNewswire

May 07, 2025
pulisher
May 05, 2025

XOMA Royalty Corp expected to post a loss of 30 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 05, 2025

Renaissance Technologies LLC Buys 7,619 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World

May 05, 2025
pulisher
May 03, 2025

JPMorgan Chase & Co. Raises Stake in XOMA Co. (NASDAQ:XOMA) - Defense World

May 03, 2025
pulisher
May 01, 2025

XOMA Co. (NASDAQ:XOMAO) Sees Significant Increase in Short Interest - Defense World

May 01, 2025
pulisher
Apr 27, 2025

XOMA Co. (NASDAQ:XOMA) Shares Sold by Geode Capital Management LLC - Defense World

Apr 27, 2025
pulisher
Apr 21, 2025

Short Interest in XOMA Co. (NASDAQ:XOMAP) Drops By 15.9% - Defense World

Apr 21, 2025
pulisher
Apr 19, 2025

Benchmark Begins Coverage on XOMA (NASDAQ:XOMA) - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

Benchmark Initiates Coverage of XOMA Royalty CorporationPreferred Stock (XOMAP) with Buy Recommendation - Nasdaq

Apr 17, 2025
pulisher
Apr 17, 2025

Benchmark Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq

Apr 17, 2025
pulisher
Apr 17, 2025

XOMA Co. (NASDAQ:XOMAO) Sees Large Decrease in Short Interest - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals

Apr 15, 2025

Xoma Royalty Corp (XOMA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Xoma Royalty Corp 주식 (XOMA) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Hughes Owen
Chief Executive Officer
May 20 '25
Sale
25.38
25,637
650,667
62,701
BURNS THOMAS M.
SVP, Finance & CFO
May 19 '25
Option Exercise
0.00
17,773
0
33,045
BURNS THOMAS M.
SVP, Finance & CFO
May 20 '25
Sale
25.38
10,482
266,033
22,563
BVF PARTNERS L P/IL
10% Owner
May 16 '25
Sale
27.10
392,723
10,642,793
1,267,545
Sitko Bradley
Chief Investment Officer
Apr 07 '25
Buy
24.70
2,000
49,400
5,045
LIMBER JOSEPH M
Director
Apr 03 '25
Buy
25.24
17,935
452,631
16,524
LIMBER JOSEPH M
Director
Apr 04 '25
Buy
25.40
6,822
173,293
20,000
LIMBER JOSEPH M
Director
Apr 07 '25
Buy
25.60
5,243
134,221
10,000
Sitko Bradley
Chief Investment Officer
Mar 31 '25
Buy
21.04
1,245
26,201
11,484
BURNS THOMAS M.
SVP, Finance & CFO
Apr 01 '25
Buy
25.46
1,000
25,460
2,000
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):